Aromatase inhibitorFDA-approvedAdjuvant
Anastrozole
How it works
Blocks the production of estrogen in the body, preventing it from stimulating cancer cells.
Cancer types
Breast Cancer— Hormone receptor-positive
Efficacy
Anastrozole has been shown to reduce the risk of breast cancer recurrence in hormone receptor-positive patients.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Testing Anastrozole and Palbociclib in Advanced Breast Cancer | Breast Cancer | phase-2 | — | Source → |
| Fulvestrant and Anastrozole in Treating Postmenopausal Breast Cancer Patients | Breast Cancer | phase-3 | — | Source → |
| Tamoxifen and Other Hormone Treatments for Invasive Breast Cancer | Breast Cancer | phase-3 | — | Source → |
| Testing a Combination Therapy for ER-Positive, HER-2 Positive Breast Cancer | Breast Cancer | phase-2 | — | Source → |
| Hormone Therapy Side Effects in Breast Cancer Patients | Breast Cancer | observational | — | Source → |
| Genetic Variation Affects Cancer Treatment Concentrations | Breast Cancer | phase-3 | — | Source → |
| Rare Vision Loss Linked to Long-Term Anastrozole Use | Breast Cancer | observational | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.